Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban in Acute Branch Atheromatous Disease (BAD)-Related Stroke
NCT06037889Phase 3Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Nov 2023
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tirofiban in ischemic stroke, sponsored by Peking Union Medical College Hospital. Started Nov 2023; status: completed.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06037889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06037889.